Effective And Safe Use Of Cephalosporins In The Treatment Of Urinary Tract Infection
DOI:
https://doi.org/10.62480/tjms.2024.vol29.pp21-24Keywords:
antibacterial prevention, antibacterial drugs, urological operationsAbstract
The high prevalence of urinary tract infections (UTIs) determines their high significance, not only medical, but also social. Every year, UTIs are the cause of outpatient visits and emergencyя medical care from the hospital[й [1]. Recently, it has been found that причиной UTI is caused уропатогенныеby uropathogenic E. Colistrains. ТакжеAn increase in the frequency of infections caused by gram-negative microorganisms was also noted, and therefore a further search for new drugs among cephalosporin antibiotics was aimed дляat creating drugs with increased activityagainst these microorganisms. New cephalosporin antibiotics are needed because of the huge increase in the number of drug-resistant bacteria
References
Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/obshchie-stati/Sovremennoe_znachenie_cefalosporinov_pri_lechenii_infekciy_v_stacionare/#ixzz8IRwGBaRq Under Creative Commons License: Attribution 2010–2019.
Wagenlehner FME, Cloutier DJ, Komirenko AS, et al: Once-daily plazomicin for complicated urinary tract infections. N Engl J Med 380(8):729-740, 2019. doi: 10.1056/NEJMoa1801467
Hoffmann H, Stindl S, Ludwig W, et al. Enterobacter hormaechei subsp.oharae subsp.nov., E. hormaechei subsp. hormaechei comb. nov., and E. hormaechei subsp. steigerwaltii subsp. nov., three new subspecies of clinical importance. J Clin Microbiol 2005; 43:3297–303. https://doi.org/10.1128/JCM.43.7. 3297–3303.2005
Wilson BM, el Chakhtoura NG, Patel S, et al. Carbapenem-Resistant Enterobacter cloacae in patients from the US veterans health administration,
–2015. Emerg Infect Dis 2017; 23:878–80. https://doi. org/10.3201/eid2305.162034 PMID: 28418318 6. Chen J, Tian S, Nian H, et al. Carbapenem-resistant Enterobacter cloacae complex in a tertiary hospital in northeast China, 2010–2019. BMC Infect Dis 2021; 21:611.
Sidorenko S. V. Treatment of community-acquired urinary tract infections –
the value of antibiotic resistance. // All-Russian scientificо- and practical conference "Modern principles of diagnosis, prevention and treatment of infectious and inflammatory- ванийdiseases of the kidneys, urinary tract and genitals" 8-9 February 2007. Abstracts of reports, pp. 124-127.
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70
Amir J., Harel L., Eidlitz–Markus T., Varsano I. Comparative evaluation of cefixime versus amoxicillinclavulanate following ceftriaxone therapy of pneumonia // Clin Pediatr (Phila). 1996. Vol. 35 (12). pp.629-633.
Hodson E.M., Willis N.S., Craig J.C. Antibiotics for acute pyelonephritis in children // Cochrane Database Syst Rev. 2007 (4). CD003772.
Ashkenazi S., Amir J., Waisman Y., Rachmel A., Garty B.Z., Samra Z., Varsano .I, Nitzan M. A randomized, double–blind study comparing cefixime and trimethoprim–sulfamethoxazole in the treatment of childhood shigellosis // J Pediatr. 1993. Vol. 123 (5). Р. 817–821.
The original article is published on the website of Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya farmakologiya/Cefiksim terapii bakterialynyh infekciy voprosy effektivnosti
Under Creative Commons License: Attribution The original article is published on the website of RMJ (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya_farmakologiya/Cefiksim_v_terapii_bakterialynyh_infekciy_voprosy_effektivnosti_i_bezopasnosti/#ixzz8J1fZ5ROU
Under Creative Commons License: Attribution
The original article is published on the website of Breast Cancer (Russian Medical Journal): https://www.rmj.ru/articles/klinicheskaya_farmakologiya/Cefiksim_v_terapii_bakterialynyh_infekciy_voprosy_effektivnosti_i_bezopasnosti/#ixzz8J1fNfdNs
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
